A Multimodal Prehabilitation Feasibility Study for Older Adult Patients at High Risk for Poor Postoperative Outcomes Prior to Esophageal Cancer Surgery
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this research study is to investigate the feasibility of implementing a prehabilitation program that aims to improve a patient's physical, nutritional, and sleep health before surgery in an older, at-risk group with esophageal cancer.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Healthy Volunteers: f
View:
• 65 years of age and over
• Adult male or non-pregnant female volunteers
• Completed neoadjuvant chemotherapy or radiotherapy for esophageal cancer
• At least four weeks to esophageal cancer surgery
• Without skin conditions that preclude wearing sensors
• Able to speak English and consent
Locations
United States
Massachusetts
Massachusetts General Hospital
RECRUITING
Boston
Contact Information
Primary
Hassan Dashti, PhD
Hassan.dashti@mgh.harvard.edu
6177269132
Backup
Federico Ciardi, MBBS
fciardi@mgh.harvard.edu
646-574-7682
Time Frame
Start Date: 2023-12-01
Estimated Completion Date: 2026-01-31
Participants
Target number of participants: 30
Treatments
Experimental: Prehabilitation Program
30 participants will be enrolled and will complete study procedures as follows:~* Enrollment at least 4 weeks prior to esophageal cancer surgery.~* In-person clinic visit with dietitian and physical therapist for assessments, and completion of baseline questionnaires with study coordinator.~* Adherence to daily physical function, dietary, and sleep recommendations and consumption of 5-day immunonutrition supplement.~* Regular electronic/phone-call check-ins with study staff.~* Telehealth appointment with physical therapist and dietitian prior to surgery.~* After surgery and during hospital admission, final visit with dietitian and physical therapist for assessments, and completion of questionnaires.~* 6-month follow-up period.
Related Therapeutic Areas
Sponsors
Leads: Massachusetts General Hospital